Table 3.

Proportion of low and high activation level respondents with reported change in measured PAM-13 domains

		Patient’s activation level		χ2(DF), p
		Low level of activation (PAM-13 levels 1 and 2, n = 46)	High level of activation (PAM-13 levels 3 and 4, n = 96)
Increased assistance with ADL	No	58.7%	83.2%	χ2 (1) = 9.94, p = 0.002
	Yes	41.3%	16.8%
Worsening of disease symptoms	No	40%	63.8%	χ2 (1) = 7.02, p = 0.008
	Yes	60%	36.2%
Increased tiredness	No	33.3%	67%	χ2 (1) = 14.02 P < 0.001
	Yes	66.7%	33%
Lack of family members’ and friends’ support	No	30.4%	63.5%	χ2 (1) = 13.68 p < 0.001
	Yes	69.6%	36.5%

ADL activities of daily living, PAM Patient Activation Measure